Clinical management of hepatitis B virus infection correlated with liver transplantation |
| |
Authors: | Jian Zhang Lin Zhou Shu-Sen Zheng Key Laboratory of Combined Multi-Organ Transplantation Ministry of Public Health Key Laboratory of Organ Transplantation Zhejiang Province First Affiliated Hospital Zhejiang University School of Medicine Hangzhou China |
| |
Affiliation: | Jian Zhang,Lin Zhou , Shu-Sen Zheng Key Laboratory of Combined Multi-Organ Transplantation,Ministry of Public Health,Key Laboratory of Organ Transplantation,Zhejiang Province,First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China |
| |
Abstract: | BACKGROUND:As a radical cure for post-hepatitis B virus (HBV)-related liver cirrhosis and hepatocellular carcinoma,liver transplantation has been applied in many medical centers.Before the use of effective measures,hepatitis B recurrence and the existence of HBsAg(+) donors,patients with hepatitis B-related diseases are contraindicated for liver transplantation.Application of interferon,hepatitis B immunoglobulin (HBIG),and nucleotide analogues (e.g.,lamivudine) has made great progress in the clinical care ... |
| |
Keywords: | hepatitis B vaccination hepatitis B immunoglobulin lamivudine liver transplantation adefovir hepatitis B virus genotype |
本文献已被 CNKI 等数据库收录! |
|